Author： Bansal Shyam S.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.24, Iss.6, 2007-01, pp. : 441-451
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cyclo-Oxygenase-2 Inhibitors and the Kidney: A Case for Caution
Drug Safety, Vol. 25, Iss. 3, 2002-01 ,pp. :
Access to resources
Recommend
Cyclo-Oxygenase-2 Inhibitors: When Should They Be Used in the Elderly?
By Savage Ruth
Drugs & Aging, Vol. 22, Iss. 3, 2005-01 ,pp. :
Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease
By McGeer P.L.
Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. :
Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?
By Yuan Yuhong Hunt Richard H.
Inflammopharmacology, Vol. 11, Iss. 4-6, 2003-12 ,pp. :